Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
Describe the efficacy of the use of topical besifloxacin in reducing the conjunctival
microbiota as a prophylactic measure in patients scheduled for cataract surgery.
Phase:
Phase 1
Details
Lead Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana